Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim Day 2 vs Day 4 with CHOP +/- Rituximab in Older Patients with Aggressive Non-Hodgkin's Lymphoma
NCT00726700Phase 2Completed
- Sponsor
- Saarland University
- Start
- May 2004
- Primary completion
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pegfilgrastim in B-cell non-Hodgkin lymphoma, sponsored by Saarland University. Started May 2004; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00726700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726700.